Detalhe da pesquisa
1.
Baricitinib in Patients with Refractory Rheumatoid Arthritis.
N Engl J Med
; 374(13): 1243-52, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028914
2.
The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib.
Clin Exp Rheumatol
; 37(4): 694-704, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30767864
3.
Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.
Ann Rheum Dis
; 77(7): 988-995, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463520
4.
Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis.
Rheumatology (Oxford)
; 57(5): 900-908, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415145
5.
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).
Ann Rheum Dis
; 76(4): 694-700, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27799159
6.
Safety and efficacy of baricitinib at 24â weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.
Ann Rheum Dis
; 74(2): 333-40, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25431052
7.
Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib.
ACR Open Rheumatol
; 4(3): 254-258, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34913611
8.
Circulating endothelial and endothelial progenitor cells in patients with severe sepsis.
Microvasc Res
; 81(2): 216-21, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21130783
9.
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT).
Trials
; 22(1): 689, 2021 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34627340
10.
Destabilizing the 'equipoise' framework in clinical trials: prioritizing non-exploitation as an ethical framework in clinical research.
Nurs Philos
; 11(4): 271-9, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20840138
11.
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
EMBO Mol Med
; 12(8): e12697, 2020 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473600
12.
Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial.
J Clin Med
; 8(6)2019 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31212775
13.
Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid Arthritis.
J Rheumatol
; 45(1): 14-21, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28811354
14.
Characterization and Changes of Lymphocyte Subsets in Baricitinib-Treated Patients With Rheumatoid Arthritis: An Integrated Analysis.
Arthritis Rheumatol
; 70(12): 1923-1932, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30058112
15.
Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.
RMD Open
; 4(1): e000662, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29765703
16.
Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid Arthritis.
Arthritis Rheumatol
; 69(5): 943-952, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28029752
17.
Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis.
RMD Open
; 3(2): e000546, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29071120
18.
Protein C in critical illness.
Am J Health Syst Pharm
; 66(12): 1089-96, 2009 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19498123